RSS
sustained-release
Merck & InnoCore Pharmaceuticals enter cooperation agreement for drug delivery platform
Science and technology company, Merck, has entered into a cooperation agreement with Netherlands-based InnoCore Pharmaceuticals, for a new drug delivery platform that will aim to improve patient compliance. Read more
New schizophrenia drug may improve patient compliance
A new pipeline drug, RBP-7000, developed by Indivior for the treatment of schizophrenia, has the potential to improve patient compliance, according to research performed by consulting firm GlobalData. Read more
